baber/WOPTO huggingface dataset:
Patent CA-2661424-A1 (CA)
Inventor: FONTAINE NORSTON
IPC: B66D3/04
Filed: 2009-04-06
Abstract: Embodiments of the present invention provide pulley apparatuses that can be easily incorporated into block-and-tackle configurations. In some embodiments, a rope can be easily dropped into place and removed, rather than having to be threaded in.  For example, the pulley housing can include a rope channeling structure near the end opposite the aperture, and the rope channeling structure can facilitate introducing the rope into engagement with the wheel and/or removing the rope from engagement with the wheel. In some embodiments, the rope channeling structure can prevent the rope from inadvertently becoming removed from the pulley. Some pulley apparatuses can comprise a minimal number of parts, which can significantly simplify the manufacturing process and provide for a more consistent final product.
Patent CA-2664962-A1 (CA)
Inventor: NACHUM SAGI
IPC: G06F17/30
Filed: 2009-04-29
Abstract: A method for automatically providing a plurality of additional database query terms to a user is provided. The method comprises receiving a query term from a user, receiving a plurality of characters from the user in addition to the query term, and selecting a set of records from a database based on the query term, wherein the database comprises records, and the records comprise text translated from audio. The method also determines a plurality of additional query terms based on the plurality of characters, and, for at least one of the plurality of additional query terms, processes at least a portion of the set of records to determine a relevance of the additional query term.  Finally, the method includes displaying at least one of the plurality of additional query terms to the user for selection, the display based on the relevance of the at least one of the plurality of additional query terms.
Patent CA-2666019-A1 (CA)
Inventor: MURPHY PATRICK
IPC: C12N15/82
Filed: 2007-10-11
Abstract: Proteins that are associated with increased after-cooking darkening (ACD) are described. The proteins are useful in diagnostic assays for detecting ACD. Inhibiting or activating the proteins can also be useful in controlling and/or reducing ACD.
Patent CA-2667828-A1 (CA)
Inventor: HODGES STEPHEN E
IPC: G16H10/20
Filed: 2007-12-06
Abstract: A system that can enable clinical trial compliance determination by viewing sequences of images captured during an event is disclosed. For example, the innovation can employ captured event sequences to enable a subject or third party to assess a subject's actions related to a medical trial. The capture of event sequences can be triggered based upon sensory data, radio frequency identification (RFID) data, pattern recognition data, etc. The system also provides mechanisms to locate images or sequences, playback images or sequences or images as well as to set compliance parameters associated with a particular clinical trial.
Patent CA-2668350-A1 (CA)
Title: Engine generator
Inventor: HIRANUMA JUNJI
IPC: H02K7/18
Filed: 2009-06-08
Abstract: An engine generator accommodating an engine and a generator inside a case. A first stationary handle that extends in the width direction is mounted in the rear section of the case. A second stationary handle is mounted on the upper front part of the case. A draw handle is provided so as to swing in the vertical direction in relation to the second stationary handle. The second stationary handle is manually grasped and the engine generator is moved. The first and second stationary handles are grasped and the engine generator is lifted. The draw handle is pulled to move the engine generator.
Patent CA-2669066-A1 (CA)
Inventor: DRIANCOURT MARC-ANTOINE
IPC: A61K9/00
Filed: 2007-11-19
Abstract: The present invention relates to a helically-shaped medicated veterinary system suitable for delivery of a drug to the vaginal cavity of a female non-human mammal and to a method of manufacture. The drug delivery system is helically-shaped and comprises a three layered polymer fibre. The polymer fibre comprises a polymer core, a polymer intermediate layer comprising a drug, and a polymer skin. The medicated system provides a controlled delivery of drug to the vaginal cavity of the mammal. The present invention also relates to a process of making the springs.
Patent CA-2669796-A1 (CA)
Inventor: SUGIYAMA TAKESHI
IPC: C22B1/16
Filed: 2007-11-07
Abstract: Briquette iron obtained by the hot-molding of reduced-iron particles, the reduced-iron particles being adherent to one another. The reduced-iron particles each has a surface region which has an average carbon content of 0.1-2.5 mass% and a central region which is located inside the surface region and has a higher average carbon content than the surface region.
Patent CA-2670561-A1 (CA)
Inventor: ROTELLA JOHN A
IPC: A61B17/04
Filed: 2007-08-10
Abstract: The invention describes an apparatus and method of use for anchoring two or more body tissue layers to one another. The apparatus includes a plurality of individual anchor segments (28) that are placeable within a body cavity. The segments may assume a first relaxed state wherein the segments are movable relative to each other and alignable along an initial longitudinal axis (20) for initial placement of the apparatus through the body tissue layers. Once placed within the body cavity, the anchor segments are manipulated into a second rigid state with an actuator wherein the.segments assume a rigid configuration at a transverse angle relative to the initial longitudinal axis.
Patent CA-2671799-A1 (CA)
Inventor: AGARWAL SAMEER
IPC: A61K31/575
Filed: 2007-12-07
Abstract: The present invention relates to the use of cholesterylamines in the preparation of pharmaceutical compositions. These pharmaceutical compositions are to be used in the medical intervention of infectious diseases, in particular diseases caused by a virus or a bacterium.
Patent CA-2673459-A1 (CA)
Title: Modified coagulation factors with prolonged in vivo half-life
Inventor: SCHULTE STEFAN
IPC: A61K38/37
Filed: 2007-12-21
Abstract: The present invention relates to modified nucleic acid sequences coding for coagulation factors preferably coagulation factor VIII and their derivatives, recombinant expression vectors containing such nucleic acid sequences, host cells transformed with such recombinant expression vectors, recombinant polypeptides and derivatives coded for by said nucleic acid sequences which recombinant polypeptides and derivatives do have biological activities and prolonged in vivo half-life compared to the unmodified wild-type protein. The invention also relates to corresponding sequences that result in improved in vitro stability. The present invention further relates to processes for the manufacture of such recombinant proteins and their derivatives are covered. The invention also relates to a transfer vector for use in human gene therapy, which comprises such modified nucleic acid sequences.
Patent CA-2674144-A1 (CA)
Inventor: MOURELLE MANCINI MARISABEL
IPC: A61P27/06
Filed: 2007-12-27
Abstract: The present invention relates to the use ofa compound of formula (I) or a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof: as active ingredient(s) in the manufacture of a pharmaceutical composition for the prevention and/or treatment of ophthalmological diseasesmediated by ocular hypertension.
Patent CA-2674509-A1 (CA)
Title: Edible film-shaped preparation with cola taste
Inventor: ASMUSSEN BODO
IPC: A23L35/00
Filed: 2007-12-12
Abstract: The invention relates to edible foil-shaped coke-flavored preparations which quickly disintegrate in a residue-free manner when coming in contact with moisture.
Patent CA-2676292-A1 (CA)
Title: Cell co-culture systems and uses thereof
Inventor: MITSIADES CONSTANTINE S
IPC: C12M1/34
Filed: 2008-02-01
Abstract: The invention provides a cell co-culture for the selective evaluation of the response of a cell of interest in the co-culture, and methods of using the co-culture. The cell co-culture and the methods are suitable for large-scale / high throughput screening for compounds useful for affecting at least one biological function or event of at least one cell type in the co-culture. The invention further provides kits for using the screening assays.
Patent CA-2676767-A1 (CA)
Title: Method of driving a well pump
Inventor: WELLS ROBERT MICHAEL
IPC: E21B43/12
Filed: 2009-08-31
Abstract: Production liquid from a well is pumped to the surface by a hydraulically driven reciprocating piston pump. The pump is driven in a drive stroke by a flow of hydraulic fluid supplied through a single tubing line applied to a drive side of a drive piston and in a return stroke by the weight of the production liquid heavier than the hydraulic fluid applied to the return side of the drive piston. The production liquid is pumped though the well casing. A control valve causes application of pressure in the hydraulic fluid for the drive stroke and release for the return stroke. The pump body includes a first duct communicating between the tubing and the bottom drive side of the drive piston and a second duct communicating between the well casing and the top drive return of the drive piston.
Patent CA-2677361-A1 (CA)
Inventor: ADAMS DAVID
IPC: A61F2/24
Filed: 2008-02-08
Abstract: A set of annuloplasty rings progressively sized to take into account more of the common pathologies. The proportional shapes of each ring as the orifice size changes vary. For instance, the larger rings have larger minor axis dimensions relative to their major axis dimensions.
Patent CA-2677392-A1 (CA)
Inventor: EKONEN TODD
IPC: F16H37/08
Filed: 2009-09-01
Abstract: A vehicle drive train for transferring torque to first and second sets of wheels includes a first driveline adapted to transfer torque to the first set of wheels and a first power disconnection device. A second driveline is adapted to transfer torque to the second set of wheels and includes a second power disconnection device. A hypoid gearset is positioned within one of the first driveline and the second driveline in a power path between the first and second power disconnection devices. The hypoid gearset is selectively disconnected from being driven by either of the first driveline and the second driveline when the first and second power disconnection devices are operated in a disconnected, non-torque transferring, mode.
Patent CA-2678265-A1 (CA)
Inventor: CHEN MINGWEI
IPC: C07C233/29
Filed: 2008-02-11
Abstract: The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistence and hyperglycemia. The present invention also provides for processes of making the compounds of Formula I, including salts and co-crystals thereof, and pharmaceutical compositions comprising the same.
Patent CA-2679355-A1 (CA)
Inventor: OESTMAN PATRIK
IPC: G06F11/36
Filed: 2008-02-21
Abstract: The present invention is related to a method, a system and a computer readable device for authenticated configuration used for configuration of software probes in software modules to be tested in an electrical mobile device. The invention will create and make use of a configuration file by inserting an authentication signature, Probe Identifications (PID) and Probe Locations (PL).
Patent CA-2681103-A1 (CA)
Title: Smart nema outlets and associated networks
Inventor: CHAPEL STEVE
IPC: H02B1/28
Filed: 2008-03-14
Abstract: A control system (300) allows standard NEMA receptacles to be remotely monitored and/or controlled, for example, to intelligently execute blackouts or brownouts or to otherwise remotely control electrical appliances. The system (300) includes a number of smart receptacles (302) that communicate with a local controller (304), e.g., via power lines using the TCP/IP protocol. The local controller (304), in turn, communicates with a remote controller (308) via the internet.
Patent CA-2681123-A1 (CA)
Inventor: MATTEUCCI PAUL
IPC: B23C5/08
Filed: 2008-03-07
Abstract: Cutting tool comprising a structural member (1, 1') provided with means (301, 401 ) for engagement with operating means, and a plurality of cutting edges (201, 201') connected to said structural member (1, 1'), intended to follow a given cutting path; said cutting edges (201, 201') are each connected to said structural member (1, 1') by means of a suitable support part (101, 101') connected at one end to said structural member (1, 1'), oriented in a manner substantially perpendicular to the plane of said cutting path and having said cutting edge (201, 201') at its free end, the cutting edges (201, 201') connected to two adjacent support parts being arranged in substantial opposition to each other with respect to said cutting path.
Patent CA-2683698-A1 (CA)
Inventor: YOO MOOHI
IPC: A61K9/52
Filed: 2008-04-18
Abstract: Disclosed are biodegradable microspheres, capable of releasing a glucose-regulating peptide in a controlled manner, comprising a biodegradable polymer carrier with the glucose-regulating peptide encapsulated therein, and methods for the preparation thereof. In addition to ensuring high encapsulation efficiency and high stability of the encapsulated drug, the microspheres shows neither an initial burst effect nor incomplete release and allows the zero-order release of drugs over a prolonged period of time, thus improving the therapeutic effect of the drug.
Patent CA-2685534-A1 (CA)
Inventor: MCLAUGHLIN RONALD P
IPC: A61P9/00
Filed: 2008-04-30
Abstract: The application of matrix metalloproteinase (MMP) inhibitors to the skin inhibits the degradation of proteins found in the skin including collagen, elastin, and other basement membrane and extracellular matrix protein. MMP inhibitors may be used in both cosmetic compositions and pharmaceutical compositions for application to skin. MMP inhibitors are formulated with a cosmetically suitable vehicle or pharmaceutically acceptable excipient for application to the skin as creams, lotions, ointments, solutions, face masks, etc. As cosmetics, the inventive MMP inhibitor compositions are applied to the skin to prevent or reduce the appearance of wrinkles, pigmentation changes, loss of elasticity, or other effects associated with aging or sun damage. As pharmaceuticals, the inventive MMP inhibitor compositions may also be applied to the skin to treat or prevent a skin disease (e.g., proliferative disease, inflammatory disease).
Patent CA-2688338-A1 (CA)
Inventor: JACOBS GREGORY F
IPC: E04G21/14
Filed: 2008-05-23
Abstract: Photocatalytic roofing granules include a binder and inert mineral particles, with photocatalytic particles dispersed in the binder.
Patent CA-2688364-A1 (CA)
Inventor: OLAN MIKA
IPC: C03B23/033
Filed: 2008-06-13
Abstract: The invention relates to a method and apparatus for bending a glass panel. A heated flat glass panel (G) is fed from a furnace (1) onto a bending conveyor (4) while the bending conveyor (4) is in a straight configuration. The bending conveyor (4) and the glass panel are arched to a desired curvature while the glass panel travels along the bending conveyor (4). The bent glass panel is passed from the bending conveyor (4) onto a tempering conveyor (5) present as its extension, which has been previously arched to a desired curve as early as or even prior to having the flat glass panel received by the straight bending conveyor (4).
Patent CA-2689890-A1 (CA)
Title: Method of manufacturing an intracutaneous microneedle array
Inventor: SHERMAN FAIZ F
IPC: A45D34/04
Filed: 2000-06-07
Abstract: A microneedle array is manufactured using a mold preparation procedure that begins try placing an optical mask over a layer of PMMA material, exposing the PMMA  material to x-rays, then developing using a photoresist process. The remaining PMMA material is then electroplated with metal. Once the metal has reached an appropriate thickness, it is detached to become a metal mold that is used in a microembossing procedure, in which the metal mold is pressed against a heated layer of plastic material. Once the mold is pressed down to its proper distance, the plastic material is cooled until solidified, and the mold is then detached, thereby leaving behind an array of microneedles. If the microneedles are hollow, then an additional procedure is used to create through-holes all the way through the underlying substrate material using laser optical means.
Patent CA-2690322-A1 (CA)
Title: Bruleur pilote air-gaz pouvant fonctionner a l'oxygene
Inventor: LAURENT JACKY
IPC: F23D14/26
Filed: 2010-01-15
Abstract: Système comprenant au moins un brûleur pilote et un brûleur principal plus puissant, ledit brûleur pilote comprenant : - au moins un premier tube ouvert à une extrémité et comportant au moins une première ligne d'amenée apte à admettre un gaz combustible dans ledit premier tube; et - au moins un second tube ouvert à une extrémité et comportant au moins une troisième ligne d'amenée apte à admettre un gaz riche en oxygène dans ledit second tube; caractérisé en ce que ledit brûleur pilote comprend en outre, au moins une seconde ligne d'amenée apte à alimenter en air ledit premier tube.
Patent CA-2691227-A1 (CA)
Inventor: LAIHO MARIKKI
IPC: C07D239/88
Filed: 2008-06-19
Abstract: La présente invention concerne des procédés d'identification  de composés de petites molécules qui sont des activateurs de la voie  de la protéine p53 de suppression de la tumeur, et des éléments  p63 et p73 de la famille qui lui sont associés. L'invention concerne  en outre des procédés consistant à tuer des cellules tumorales  et à traiter les cancers ou autres conditions nécessitant l'activation  des voies d'un élément de la famille de p53 et des voies de réponse  à un dommage de l'ADN avec les petites molécules.
Patent CA-2694539-A1 (CA)
Title: System and method for a simple graphical interface
Inventor: BOUKHNY MIKHAIL
IPC: G06F19/00
Filed: 2008-06-20
Abstract: Embodiments of systems and methods for a simplified interface are disclosed.  More specifically, embodiments of modes of interaction with a surgical console may be provided such that these modes of interaction limit or curtail the range of functionality which may be adjusted. In particular, certain embodiments may present one or more interfaces for user interaction which allow a user to select from a set of preprogrammed options, where the interface or the set of preprogrammed options may correspond to the mode in which a user is interacting with the surgical console. Each of these preprogrammed options may correspond to settings for one or more parameters such that by selecting a preprogrammed option the surgical console is configured according to these settings.
Patent CA-2696818-A1 (CA)
Title: Hydrocarbon and alcohol fuels from variable, renewable energy at very high efficiency
Inventor: DOTY F DAVID
IPC: C01B32/40
Filed: 2008-03-19
Abstract: A Renewable Fischer Tropsch Synthesis (RFTS) process produces hydrocarbons and alcohol fuels from wind energy, waste CO2 and water. The process includes (A) electrolyzing water to generate hydrogen and oxygen, (B) generating syngas in a reverse water gas shift (RWGS) reactor, (C) driving the RWGS reaction to the right by condensing water from the RWGS products and separating CO using a CuA1C14-aromatic complexing method, (D) using a compressor with variable stator nozzles, (E) carrying out the FTS reactions in a high-temperature multi-tubular reactor, (F) separating the FTS products using high-pressure fractional condensation, (G) separating CO2 from product streams for recycling through the RWGS reactor, and (H) using control methods to maintain temperatures of the reactors, electrolyzer, and condensers at optima that are functions of the flow rate. The RFTS process may also include heat engines, a refrigeration cycle utilizing compressed oxygen, and a dual-source organic Rankine cycle.
Patent CA-2696910-A1 (CA)
Inventor: WANG HAO
IPC: C10G1/04
Filed: 2010-03-15
Abstract: A system for extracting a component from a composition is disclosed and includes an extraction and separation device containing the composition that receives a supercritical fluid, wherein the supercritical fluid extracts the component from the composition and is then separated from the component. The system may also include a feed pump that receives and pressurizes a fluid, wherein the component is resolvable to the fluid in a supercritical phase; a solar collector that receives the fluid from the feed pump and heats the fluid to a supercritical phase to form a supercritical fluid, wherein the extraction and separation device receives the supercritical fluid from the solar collector; and a heat exchanger that receives the fluid from the extraction and separation device and cools the fluid for returning to the feed pump. A method utilizing this system is also disclosed.
Patent CA-2700369-A1 (CA)
Inventor: MINATO HIRONAO
IPC: A61F13/15
Filed: 2008-07-11
Abstract: The present invention aims to provide an improved absorbent article which alleviates any possible skin irritation experienced by a wearer when a barrier sheet comes in contact with the wearer's skin, and which prevents pressure marks from being left on the wearer's skin due to contact between the barrier sheet and the diaper wearer's skin.     A liquid-absorbent chassis 2 is provided on an inner surface 100 thereof which faces the wearer's skin, by means of a barrier sheet 8 which comprises front and rear passage openings 27, 28 defined by lateral portions 34, 35 and a middle portion 26, and barrier sheet elastic members 33 functioning to space the barrier sheet 8 upwardly from the liquid-absorbent chassis 2. The barrier sheet 8 includes first adhesion sites 40, 41 at which front and rear end portions 24, 25 are bonded to the barrier sheet 8, second adhesion sites 42 at which convex segments 36 of the barrier sheet elastic members 33 are bonded to the barrier sheet 8 and third adhesion sites 43 defined between respective pairs of first adhesion sites 40, 41 and a pair of the second adhesion sites 42 and at which segments of the barrier sheet elastic members 33 occupying these sites 43 are bonded to the barrier sheet 8. The adhesive forming the second and third adhesion sites 42, 43 has a basis weight lower than the basis weight of the adhesive forming the first adhesion sites 40, 41.